Cancer therapeutics: Pulling the plug on BCL-X(L)
Nat Chem Biol
.
2013 Jun;9(6):351-2.
doi: 10.1038/nchembio.1256.
Authors
Paul S Jeng
1
,
Emily H Cheng
Affiliation
1
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
PMID:
23689630
DOI:
10.1038/nchembio.1256
No abstract available
Publication types
Comment
MeSH terms
Animals
Antineoplastic Agents / pharmacology*
Drug Design*
Humans
bcl-X Protein / antagonists & inhibitors*
bcl-X Protein / chemistry*
Substances
Antineoplastic Agents
bcl-X Protein